👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

European bank stocks outpace market before stress tests

Published 24/10/2014, 11:53
© Reuters Sun is seen over the euro sign landmark next to the head quarters of the European Central Bank prior to the ECB's monthly press conference in Frankfurt
UK100
-
BASFN
-
VOLVb
-
PRTP
-
BMPS
-
FTEU3
-

By Sudip Kar-Gupta

LONDON (Reuters) - European shares pared early losses on Friday as investors bet the fallout for the banking sector from stress test results due on Sunday should be contained, and took a more measured view of New York's first case of Ebola.

The banking index rose 0.3 percent, boosted by hopes that the weekend update on the sector's financial health from the European Central Bank should not reveal too many problems.

Banca Monte dei Paschi di Siena (MI:BMPS) shares surged 8 percent as traders said the bailed-out Italian lender could pass the health checks relatively unscathed.

The FTSEurofirst 300 index (FTEU3) of top European shares fell 0.2 percent to 1,316.44 points by the middle of the trading session.

It earlier declined as much as 0.6 percent on news a New York City doctor who treated Ebola patients in West Africa had become the first person to test positive for the virus in the U.S. financial hub.

Joe Rundle, head of trading at ETX Capital, told Reuters Insider Television that one of the problems about Ebola was that investors still could not quantify the kind of impact it might have on the world economy.

"People have no idea how to price it," said Rundle. (http://reut.rs/103vt9h)

Others felt the Ebola worries might be exaggerated.

"I think the fears are a bit overdone. In previous cases, such as avian flu, the virus ended up being contained quite quickly," said Caroline Vincent, European equities fund manager at Cavendish Asset Management.

EARNINGS TAKE A BACK SEAT

The concerns relegated the latest batch of data from the European earnings season to a subsidiary role.

Luxury goods group Kering (PA:PRTP) fell 4.2 percent, making it the worst-performing stock on the pan-European FTSEurofirst 300 index (FTEU3) after sales fell at its Gucci brand.

Chemicals company BASF (DE:BASFn) declined by 2.6 percent after cutting its 2015 earnings forecast on weak demand in its European home markets.

Global truck maker Volvo (ST:VOLVb) outpaced the market, jumping 10 percent after a surprise rise in core earnings.

The FTSEurofirst 300 index has rebounded slightly this week to put it on course for its best week since December 2013, but many investors have still continued to slash exposure to European equities, which have been knocked back over the last month by weak European economic data.

U.S.-based funds invested in European shares seeing outflows for a third straight week, according to Lipper data.

A Lipper survey of 109 U.S.-domiciled funds investing in European shares, including exchange-traded funds (ETFs), showed redemptions of $958 million in the seven days to Oct 22, adding to the record weekly outflows of $1.33 billion from last week.

Europe bourses in 2014: http://link.reuters.com/pap87v

Asset performance in 2014: http://link.reuters.com/gap87v

© Reuters. Sun is seen over the euro sign landmark next to the head quarters of the European Central Bank prior to the ECB's monthly press conference in Frankfurt

(additional reporting by Blaise Robinson, Francesco Canepa and Stephen Jewkes, editing by John Stonestreet)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.